Sucrose Malabsorption Found in SIBO-Negative Patients

Byalsapataca
🟢
Peer-Reviewed Research

One in Five SIBO-Negative Patients Had a Different Carbohydrate Problem

A team at Beth Israel Deaconess Medical Center discovered that 22% of patients with negative breath tests for small intestinal bacterial overgrowth (SIBO) tested positive for sucrose malabsorption. Led by Ramprasad C and colleagues, the 2026 study found no differences in symptom profiles between the two conditions. This finding highlights a fundamental challenge: the classic symptoms of Irritable Bowel Syndrome (IBS)—bloating, pain, altered bowel habits—are not unique. They point to a dysfunctional gut, not a single root cause.

This article explains the complex overlap between SIBO and IBS, why clinical diagnosis based on symptoms is unreliable, and the evidence-based strategies required for accurate differentiation and effective management.

Why SIBO and IBS Are Not Interchangeable Diagnoses

SIBO and IBS are distinct clinical entities that share a common presentation. Confusing them often leads to treatment failure and patient frustration.

SIBO: A Microbial Problem in the Wrong Place

Small Intestinal Bacterial Overgrowth is a condition characterized by an excessive number or abnormal type of bacteria colonizing the small intestine. Normally, this part of the gut has relatively low bacterial counts. When bacteria overpopulate it, they ferment food prematurely, producing gas (hydrogen, methane, hydrogen sulfide) and potentially causing inflammation and impaired nutrient absorption.

IBS: A Disorder of Gut-Brain Interaction

Irritable Bowel Syndrome is classified as a disorder of gut-brain interaction (DGBI). Its diagnosis, per the Rome IV criteria, is based on the presence of recurrent abdominal pain related to defecation or associated with a change in stool frequency or form. Crucially, this diagnosis is made after excluding other organic diseases. IBS involves altered gut motility, visceral hypersensitivity (an increased pain response in the gut), and dysfunctional communication between the brain and the enteric nervous system.

The Overlap: Shared Symptoms, Different Mechanisms

The gas, inflammation, and motility changes caused by SIBO can produce symptoms that perfectly mimic IBS: bloating, distension, abdominal pain, diarrhea, and/or constipation. Research suggests SIBO is more prevalent in IBS patients than in healthy controls, but it is not the cause for everyone. SIBO can be a primary driver of symptoms or a secondary complication of the slow gut motility often seen in IBS, particularly the constipation-predominant subtype (IBS-C). For a deeper look at managing this specific overlap, see our article on IBS-C Management: Circadian Rhythms and SIBO.

Symptom Questionnaires Cannot Tell SIBO, IBS, or Carbohydrate Malabsorption Apart

The Beth Israel study provides direct evidence against symptom-based differentiation. Researchers administered three standardized symptom assessments—the Rome IV Questionnaire, IBS Severity Scoring System (IBS-SSS), and the PAGI-SYM—to 300 patients undergoing SIBO breath testing.

Identical Scores for Different Conditions

When comparing patients who tested positive for sucrose malabsorption to those who tested negative, the team found no statistically significant differences. Scores for abdominal pain, bloating frequency, severity scores, and even Rome IV diagnoses (like IBS, functional constipation, or diarrhea) were the same. The only distinction emerged when comparing pure groups: patients with only sucrose malabsorption reported less abdominal pain than those with only an abnormal SIBO test.

This confirms that a patient’s description of their suffering cannot reliably pinpoint the underlying physiological disruption.

Sucrose Malabsorption: The Overlooked Mimicker

Sucrose malabsorption results from a deficiency of the enzyme sucrase-isomaltase in the small intestine. Without this enzyme, the common sugar sucrose (table sugar) cannot be broken down and absorbed. It travels to the colon where gut bacteria ferment it, producing gas, osmotic diarrhea, and bloating. The study’s finding that 22% of SIBO-negative patients had this condition means it is a significant, and likely under-diagnosed, contributor to functional GI symptoms. Its treatment—dietary modification or enzyme replacement—is entirely different from SIBO treatment with antibiotics. For a focused analysis on this diagnostic challenge, read SIBO vs Sucrose Malabsorption Symptoms.

The Critical Role of Objective Testing in Differentiation

Given the symptom overlap, moving from suspicion to diagnosis requires specific investigations. Relying on a treatment trial as a “test” is often inefficient and can be misleading.

Breath Testing: The Primary Tool for SIBO and Carbohydrate Malabsorption

Glucose or Lactulose Breath Tests are the most common non-invasive methods for diagnosing SIBO. Patients ingest a sugar solution, and their breath is analyzed at intervals for elevated levels of hydrogen and methane gas, which indicate bacterial fermentation in the small intestine.

As demonstrated in the research, a specialized 13C-Sucrose Breath Test (SBT) can diagnose sucrose malabsorption. Other tests exist for lactose (lactose breath test) and fructose malabsorption. A comprehensive evaluation for persistent IBS-like symptoms should consider these tests after common conditions like celiac disease have been excluded.

Important Limitations of Current Testing

Breath testing is helpful but imperfect. Variability in gut motility, technical differences between clinics, and a lack of universal diagnostic thresholds can affect accuracy. A negative breath test does not definitively rule out SIBO, and a positive test must be interpreted in the clinical context. The Beth Israel study’s design—only 140 of 300 patients returned the at-home sucrose test—also highlights a practical limitation of such research and clinical follow-up.

Emerging Science: The Gut-Brain-Microbiome Axis in IBS

While SIBO represents one potential disruptor, broader research is clarifying the multifactorial nature of IBS. Work by Ishihara N, Kimura S, and Hase K at Keio University focuses on how gut metabolites influence stress-induced symptoms.

Stress, Metabolites, and Gut Sensitivity

Emotional stress is a well-established trigger and risk factor for IBS. The Japanese team’s 2025 review notes that certain intestinal metabolites produced by gut bacteria can exacerbate stress-induced diarrhea. This creates a vicious cycle: stress alters gut function and possibly the microbiome, which in turn produces metabolites that increase gut sensitivity and motility, worsening symptoms. This model explains why therapies targeting the gut-brain axis, like certain antidepressants or gut-directed hypnotherapy, can be effective even in the absence of SIBO.

A Network of Contributing Factors

Ishihara and colleagues list several conditions that overlap with or correlate to IBS: psychiatric disorders, past intestinal infections (post-infectious IBS), food sensitivities, and SIBO. This network view argues against a one-size-fits-all approach. Successful treatment often requires addressing multiple contributors simultaneously, such as managing stress while also investigating for bacterial overgrowth or specific food intolerances.

A Practical Diagnostic and Management Framework

For patients and clinicians navigating this complex overlap, a structured approach is necessary.

  1. Comprehensive Clinical Assessment: A detailed history and physical exam remain essential to rule out alarm features (e.g., weight loss, rectal bleeding) that require different investigation.
  2. Exclusion of Other Organic Disease: Basic blood work (including celiac serology) and often a colonoscopy are standard first steps in diagnosing IBS.
  3. Strategic Breath Testing: For patients with predominant bloating, gas, and diarrhea, sequential or panel breath testing for SIBO and common carbohydrate malabsorptions (lactose, fructose, sucrose) should be considered. Treating only for suspected SIBO when the issue is sucrase deficiency will fail.
  4. Empiric Dietary Intervention: A supervised low FODMAP diet can be both a diagnostic and therapeutic tool. It globally reduces fermentable carbohydrates that feed bacteria (in SIBO) or that are malabsorbed (like fructose or lactose). A strong positive response warrants further investigation to identify the specific triggers. Evidence for this approach is discussed in Low FODMAP Diet Reduces Bloating Severity in IBS SIBO.
  5. Targeted Treatment: If SIBO is confirmed, targeted antibiotic therapy like rifaximin is used. For carbohydrate malabsorption, specific enzyme supplements (e.g., sucrase for sucrose) or elimination diets are the solution. For predominant IBS mechanisms, gut-brain therapies (e.g., neuromodulators, psychological therapies) or motility agents are first-line.

Key Takeaways

💊 Popular supplements

Available on iHerb (ships to 180+ countries):

Magnesium Glycinate ↗
NAC ↗
Vitamin D3 ↗
Omega-3 ↗

Affiliate disclosure: we may earn a small commission at no extra cost to you.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

Similar Posts